EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro to in vivo extrapolation to derive a metabolism factor for estimating the aggregate exposure to salicylic acid after dermal exposure of its esters

Abdulkarim Najjar iD, Sebastien Grégoire, Beate Nicol, Andreas Natsch, Nazanin Golbamaki, Fanny Boisleve, Amaia Irizar, Brian Wall, Angus Swinscoe, Valérie Masini-Etévé, Dan Selechnik, Anne Marie Api und 3 weitere

Archives of Toxicology · 2024

DOI: 10.1007/s00204-024-03749-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, 2024. Verfasst von Abdulkarim Najjar und 14 weiteren Autor:innen. Beteiligte Einrichtung: Beiersdorf AG, Beiersdorfstr. 1-9, 20245, Hamburg, Germany. Abdulkarim.Najjar@Beiersdorf.com. Hauptthemen laut MEDLINE: Salicylic Acid, Esters. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cosmetics Europe, RIFM, IFRA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As part of the safety assessment of salicylate esters in cosmetics, we developed a metabolism factor based on in vitro to in vivo extrapolation (IVIVE) to provide a better estimation of the aggregate internal exposure to the common metabolite, salicylic acid. Optimal incubation conditions using human liver S9 were identified before measuring salicylic acid formation from 31 substances. Four control substances, not defined as salicylic esters but which could be mistaken as such due to their nomenclature, did not form salicylic acid. For the remaining substances, higher in vitro intrinsic clearance (CL int, in vitro ) values generally correlated with lower LogP values. A “High-Throughput Pharmacokinetic” (HTPK) model was used to extrapolate CL int, in vitro values to human in vivo clearance and half-lives. The latter were used to calculate the percentage of substance metabolised to salicylic acid in 24 h in vivo following human exposure to the ester, i.e. the “metabolism factor”. The IVIVE model correctly reproduced the observed elimination rate of 3 substances using in silico or in vitro input parameters. For other substances, in silico only-based predictions generally resulted in lower metabolism factors than when in vitro values for plasma binding and liver S9 CL int, in vitro were used. Therefore, in vitro data input provides the more conservative metabolism factors compared to those derived using on in silico input. In conclusion, these results indicate that not all substances contribute equally (or at all) to the systemic exposure to salicylic acid. Therefore, we propose a realistic metabolism correction factor by which the potential contribution of salicylate esters to the aggregate consumer exposure to salicylic acid from cosmetic use can be estimated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salicylic AcidEstersHumansCosmeticsModels, BiologicalAdministration, CutaneousLiverHalf-LifeSkinComputer SimulationSkin Absorption

Stichwörter der Autor:innen

High-throughput pharmacokinetic modellingIVIVEMetabolism factorSafety assessmentSalicylate estersSalicylic acid

Substanzen

Salicylic AcidEstersCosmetics

Autor:innen und Institutionen

  • Beiersdorf AG, Beiersdorfstr. 1-9, 20245, Hamburg, Germany. Abdulkarim.Najjar@Beiersdorf.com.
  • L'Oreal Research & Innovation, Aulnay-Sous-Bois, France.
  • Safety and Environmental Assurance Centre, Unilever UK, Colworth Science Park, MK44 1LQ, Sharnbrook, United Kingdom.
  • Givaudan Schweiz AG, CH-8310, Kemptthal, Switzerland.
  • Chanel, Neuilly, France.
  • The International Fragrance Association (IFRA), Geneva, Switzerland.

ORCID-Profile: Abdulkarim Najjar

Förderung

  • Cosmetics Europe
  • RIFM
  • IFRA

Zitieren

APA

Najjar, A., Grégoire, S., Nicol, B., Natsch, A., Golbamaki, N., Boisleve, F., Irizar, A., Wall, B., Swinscoe, A., Masini-Etévé, V., Selechnik, D., Api, A. M., Griem, P., Hewitt, N., & Cardamone, E. (2024). In vitro to in vivo extrapolation to derive a metabolism factor for estimating the aggregate exposure to salicylic acid after dermal exposure of its esters. Archives of Toxicology. https://doi.org/10.1007/s00204-024-03749-8

Vancouver

Najjar A, Grégoire S, Nicol B, Natsch A, Golbamaki N, Boisleve F, et al. In vitro to in vivo extrapolation to derive a metabolism factor for estimating the aggregate exposure to salicylic acid after dermal exposure of its esters. Archives of Toxicology. 2024. doi:10.1007/s00204-024-03749-8

BibTeX
@article{Najjar2024,
  author = {Najjar, Abdulkarim and Grégoire, Sebastien and Nicol, Beate and Natsch, Andreas and Golbamaki, Nazanin and Boisleve, Fanny and Irizar, Amaia and Wall, Brian and Swinscoe, Angus and Masini-Etévé, Valérie and Selechnik, Dan and Api, Anne Marie and Griem, Peter and Hewitt, Nicola and Cardamone, Estefania},
  title = {In vitro to in vivo extrapolation to derive a metabolism factor for estimating the aggregate exposure to salicylic acid after dermal exposure of its esters},
  journal = {Archives of Toxicology},
  year = {2024},
  doi = {10.1007/s00204-024-03749-8}
}
Kostenlos starten →